Auna S.A. Reports Significant Growth in 2025 Financial Results
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 7 hours ago
0mins
Should l Buy AUNA?
Source: NASDAQ.COM
- Quarterly Revenue Growth: Auna S.A. reported a 7% year-over-year revenue increase in Q4 2025, reaching 1.133 billion Peruvian Soles, indicating sustained growth potential in the healthcare sector, although overall revenue remained flat compared to last year, reflecting intense market competition.
- Net Income Fluctuations: While adjusted net income rose to 136 million Peruvian Soles from 36 million the previous year, the company reported a net loss of 64 million Soles, highlighting the need for improved cost management amidst expansion efforts to enhance profitability.
- Optimistic Future Outlook: Auna anticipates approximately 12% foreign exchange neutral revenue growth in 2026, driven by commercial momentum and operational execution in core markets, demonstrating confidence in future growth that may attract more investor interest.
- Stock Price Surge: Following the earnings report, Auna's stock price surged 20.21% in after-hours trading to $5.73, reflecting a positive market reaction to the company's growth potential, which could further bolster investor confidence.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy AUNA?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on AUNA
Wall Street analysts forecast AUNA stock price to rise
1 Analyst Rating
0 Buy
1 Hold
0 Sell
Hold
Current: 4.800
Low
6.00
Averages
6.00
High
6.00
Current: 4.800
Low
6.00
Averages
6.00
High
6.00
About AUNA
Auna SA is a Luxembourg-based healthcare company. The Company has a patient- centric model providing prepaid healthcare plans, medical care, and oncology solutions, that promotes integrated healthcare system, healthy lifestyles through prevention, research, and education. It offers a wide-ranging practice and prospects that enables to deliver standard services and the possible patient outcomes. Its network includes nearly 31 healthcare network facilities, consisting of regional network of hospitals, clinics, outpatient, and wellness facilities with a total of 2,308 beds. It is also located in Mexico, Peru, and Colombia.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Serve Robotics Shares Surge After Strong Q4 Results and Upgraded Sales Guidance
- Strong Earnings Report: Serve Robotics reported a fourth-quarter adjusted loss of 34 cents per share, outperforming the expected loss of 53 cents, indicating significant improvements in cost control and operational efficiency, which bolstered investor confidence.
- Sales Performance Exceeds Expectations: The company achieved sales of $882,000, surpassing the consensus estimate of $762,500, demonstrating robust product demand that could drive future revenue growth and enhance market competitiveness.
- Significant Stock Price Increase: Following the positive earnings report, Serve Robotics shares surged 16.2% to $11.24 on Wednesday, reflecting market optimism about the company's future prospects and potentially attracting more investor interest.
- Upgraded Sales Guidance: The company raised its FY26 sales guidance, indicating management's confidence in future performance, which may further drive stock price appreciation and enhance market recognition of its long-term growth potential.
See More
Auna S.A. Reports Significant Growth in 2025 Financial Results
- Quarterly Revenue Growth: Auna S.A. reported a 7% year-over-year revenue increase in Q4 2025, reaching 1.133 billion Peruvian Soles, indicating sustained growth potential in the healthcare sector, although overall revenue remained flat compared to last year, reflecting intense market competition.
- Net Income Fluctuations: While adjusted net income rose to 136 million Peruvian Soles from 36 million the previous year, the company reported a net loss of 64 million Soles, highlighting the need for improved cost management amidst expansion efforts to enhance profitability.
- Optimistic Future Outlook: Auna anticipates approximately 12% foreign exchange neutral revenue growth in 2026, driven by commercial momentum and operational execution in core markets, demonstrating confidence in future growth that may attract more investor interest.
- Stock Price Surge: Following the earnings report, Auna's stock price surged 20.21% in after-hours trading to $5.73, reflecting a positive market reaction to the company's growth potential, which could further bolster investor confidence.
See More
Auna Reports 6% Revenue Growth in Q4
- Revenue Growth: Auna's Q4 revenue increased by 7% year-over-year to S/1.133 billion, indicating sustained commercial momentum in its core markets despite economic challenges.
- Adjusted EBITDA Decline: Adjusted EBITDA fell to S/220 million, down 14% year-over-year, with the EBITDA margin decreasing to 19.5%, reflecting pressures from cost management and intensified market competition.
- Significant Net Income Improvement: Adjusted net income rose sharply from S/36 million in the previous year to S/136 million, indicating a notable enhancement in profitability that may boost investor confidence.
- Future Outlook: Auna projects approximately 12% revenue growth for fiscal year 2026, with similar EBITDA growth expectations, showcasing the company's confidence in future growth driven by ongoing commercial execution and disciplined cost management.
See More
Auna S.A. Stock Momentum Investment Analysis
- Price Uptrend: Auna S.A.'s stock has increased by 1.5% over the past four weeks, reflecting growing investor interest, which could attract more buyers and further drive the stock price upward.
- Long-Term Return Potential: The stock gained 5.9% over the past 12 weeks, indicating its sustained momentum characteristics, allowing investors to capitalize on this trend for higher returns.
- Momentum Score Advantage: AUNA currently holds a Momentum Score of B, suggesting a higher probability of success for entering the stock at this time, and with a beta of 2.08, it indicates volatility above the market, appealing to investors seeking quick gains.
- Attractive Valuation: AUNA's price-to-sales ratio stands at 0.30, meaning investors pay only 30 cents for every dollar of sales, demonstrating that the stock remains attractively valued while exhibiting strong momentum, providing ample room for further upside.
See More
Auna Executes Addendum to PPP Agreement with EsSalud
- Project Milestone: Auna's signing of the addendum with EsSalud formally authorizes the construction of the Torre Trecca project, which is expected to commence operations in mid-2028, significantly enhancing healthcare capacity in metropolitan Lima.
- Service Expansion: Torre Trecca will provide approximately 600,000 patient services in its first operational year, with plans for annual increases, aiming to reduce waiting times for over six million insured Peruvians.
- Infrastructure Investment: The project operates under a 20-year concession framework, with Auna's construction capital expenditures reimbursed by EsSalud through progress certificates, ensuring predictable revenue streams and minimizing financial risk.
- Strategic Market Opportunity: Auna's CEO emphasized that this partnership not only expands its market reach in Peru but also enhances the company's competitiveness in the Latin American healthcare sector by delivering high-quality medical services.
See More
Auna S.A. Announces 2025 Financial Results Dates
- Earnings Release Schedule: Auna S.A. is set to report its Fourth Quarter and Full-Year 2025 financial results on March 10, 2026, after market close, which is expected to provide investors with critical performance data to assess the company's future growth potential.
- Conference Call Timing: The company will hold a conference call on March 11, 2026, at 8:00 a.m. ET to provide a detailed interpretation of the financial results and answer investor questions, thereby enhancing transparency and investor confidence.
- Quiet Period Details: Auna will enter a quiet period from February 23 to March 10, 2026, during which no public discussions related to financial performance will occur, ensuring compliance and fairness in information disclosure.
- Company Background: Auna is a leading healthcare services and plan provider in Latin America, focusing on high-complexity diseases, with a network of 31 healthcare facilities and 2,333 beds, serving 1.4 million healthcare plans, showcasing its strong integration capabilities in the Spanish-speaking markets.
See More
Serve Robotics Shares Surge After Strong Q4 Results and Upgraded Sales Guidance
- Strong Earnings Report: Serve Robotics reported a fourth-quarter adjusted loss of 34 cents per share, outperforming the expected loss of 53 cents, indicating significant improvements in cost control and operational efficiency, which bolstered investor confidence.
- Sales Performance Exceeds Expectations: The company achieved sales of $882,000, surpassing the consensus estimate of $762,500, demonstrating robust product demand that could drive future revenue growth and enhance market competitiveness.
- Significant Stock Price Increase: Following the positive earnings report, Serve Robotics shares surged 16.2% to $11.24 on Wednesday, reflecting market optimism about the company's future prospects and potentially attracting more investor interest.
- Upgraded Sales Guidance: The company raised its FY26 sales guidance, indicating management's confidence in future performance, which may further drive stock price appreciation and enhance market recognition of its long-term growth potential.
See More
Auna S.A. Reports Significant Growth in 2025 Financial Results
- Quarterly Revenue Growth: Auna S.A. reported a 7% year-over-year revenue increase in Q4 2025, reaching 1.133 billion Peruvian Soles, indicating sustained growth potential in the healthcare sector, although overall revenue remained flat compared to last year, reflecting intense market competition.
- Net Income Fluctuations: While adjusted net income rose to 136 million Peruvian Soles from 36 million the previous year, the company reported a net loss of 64 million Soles, highlighting the need for improved cost management amidst expansion efforts to enhance profitability.
- Optimistic Future Outlook: Auna anticipates approximately 12% foreign exchange neutral revenue growth in 2026, driven by commercial momentum and operational execution in core markets, demonstrating confidence in future growth that may attract more investor interest.
- Stock Price Surge: Following the earnings report, Auna's stock price surged 20.21% in after-hours trading to $5.73, reflecting a positive market reaction to the company's growth potential, which could further bolster investor confidence.
See More
Auna Reports 6% Revenue Growth in Q4
- Revenue Growth: Auna's Q4 revenue increased by 7% year-over-year to S/1.133 billion, indicating sustained commercial momentum in its core markets despite economic challenges.
- Adjusted EBITDA Decline: Adjusted EBITDA fell to S/220 million, down 14% year-over-year, with the EBITDA margin decreasing to 19.5%, reflecting pressures from cost management and intensified market competition.
- Significant Net Income Improvement: Adjusted net income rose sharply from S/36 million in the previous year to S/136 million, indicating a notable enhancement in profitability that may boost investor confidence.
- Future Outlook: Auna projects approximately 12% revenue growth for fiscal year 2026, with similar EBITDA growth expectations, showcasing the company's confidence in future growth driven by ongoing commercial execution and disciplined cost management.
See More
Auna S.A. Stock Momentum Investment Analysis
- Price Uptrend: Auna S.A.'s stock has increased by 1.5% over the past four weeks, reflecting growing investor interest, which could attract more buyers and further drive the stock price upward.
- Long-Term Return Potential: The stock gained 5.9% over the past 12 weeks, indicating its sustained momentum characteristics, allowing investors to capitalize on this trend for higher returns.
- Momentum Score Advantage: AUNA currently holds a Momentum Score of B, suggesting a higher probability of success for entering the stock at this time, and with a beta of 2.08, it indicates volatility above the market, appealing to investors seeking quick gains.
- Attractive Valuation: AUNA's price-to-sales ratio stands at 0.30, meaning investors pay only 30 cents for every dollar of sales, demonstrating that the stock remains attractively valued while exhibiting strong momentum, providing ample room for further upside.
See More
Auna Executes Addendum to PPP Agreement with EsSalud
- Project Milestone: Auna's signing of the addendum with EsSalud formally authorizes the construction of the Torre Trecca project, which is expected to commence operations in mid-2028, significantly enhancing healthcare capacity in metropolitan Lima.
- Service Expansion: Torre Trecca will provide approximately 600,000 patient services in its first operational year, with plans for annual increases, aiming to reduce waiting times for over six million insured Peruvians.
- Infrastructure Investment: The project operates under a 20-year concession framework, with Auna's construction capital expenditures reimbursed by EsSalud through progress certificates, ensuring predictable revenue streams and minimizing financial risk.
- Strategic Market Opportunity: Auna's CEO emphasized that this partnership not only expands its market reach in Peru but also enhances the company's competitiveness in the Latin American healthcare sector by delivering high-quality medical services.
See More
Auna S.A. Announces 2025 Financial Results Dates
- Earnings Release Schedule: Auna S.A. is set to report its Fourth Quarter and Full-Year 2025 financial results on March 10, 2026, after market close, which is expected to provide investors with critical performance data to assess the company's future growth potential.
- Conference Call Timing: The company will hold a conference call on March 11, 2026, at 8:00 a.m. ET to provide a detailed interpretation of the financial results and answer investor questions, thereby enhancing transparency and investor confidence.
- Quiet Period Details: Auna will enter a quiet period from February 23 to March 10, 2026, during which no public discussions related to financial performance will occur, ensuring compliance and fairness in information disclosure.
- Company Background: Auna is a leading healthcare services and plan provider in Latin America, focusing on high-complexity diseases, with a network of 31 healthcare facilities and 2,333 beds, serving 1.4 million healthcare plans, showcasing its strong integration capabilities in the Spanish-speaking markets.
See More
